Ohio
(State or Other Jurisdiction of
Incorporation or Organization)
|
95-2680965
(I.R.S. Employer Identification No.) |
Anthony C. LaPlaca
Senior Vice President and General Counsel
Invacare Corporation
One Invacare Way
Elyria, Ohio 44035
(440) 329-6000
(Name, address and telephone number, including area code,
of agent for service)
|
Copy to:
Douglas A. Neary, Esq.
Calfee, Halter & Griswold LLP
1400 KeyBank Center
800 Superior Avenue
Cleveland, Ohio 44114
(216) 622-8200 |
CALCULATION OF REGISTRATION FEE | ||||
Title of Securities to be Registered |
Amount
to be
Registered (2) |
Proposed
Maximum
Offering
Price
Per Share |
Proposed
Maximum
Aggregate
Offering
Price |
Amount of
Registration
Fee |
Common Shares, without par value (1) |
3,000,000 |
$20.13 (3) |
$60,390,000 (3) |
$3,369.76 |
(1) |
One preferred share purchase right (a “Right”) will also be issued with respect to each common share, without par value, of the registrant (the “Common Shares”). The terms of the Rights are described in the registrant’s Registration Statement on Form 8-A, dated July 8, 2005, as the same may be amended or supplemented from time to time. |
(2) |
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers such additional Common Shares as may be issued or become issuable under the terms of the Invacare Corporation 2003 Performance Plan (the “Plan”), in order to prevent dilution resulting from any stock split, stock dividend or similar transaction. |
(3) |
Estimated in accordance with Rule 457(c) and (h) under the Securities Act, solely for the purpose of calculating the registration fee and based upon the average of the high and low sales price of the Common Shares reported on the New York Stock Exchange on August 5, 2009. |
|
1. |
The registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008; |
2. |
The registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2009; |
3. |
The registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2009; |
4. |
The registrant’s Current Reports on Form 8-K filed on January 7, 2009 (under Items 5.02 and 9.01), January 23, 2009, February 19, 2009 and May 28, 2009; |
5. |
The description of the Common Shares contained in the registrant’s Registration Statement on Form 8-A, dated October 22, 1986 (Reg. No. 0-12938) and any amendments and reports filed for the purpose of updating that description; and |
6. |
The description of the Rights contained in the registrant’s Registration Statement on Form 8-A, dated July 8, 2005, and any amendments or reports filed for the purpose of updating that description; |
|
|
INVACARE CORPORATION |
|||
|
By: |
/s/ A. Malachi Mixon, III | |
A. Malachi Mixon, III | |||
Chairman of the Board
and Chief Executive Officer (Principal Executive Officer) |
|||
Signature |
Title |
| ||
/s/ A. Malachi Mixon, III |
Chairman of the Board
and Chief Executive Officer (Principal Executive Officer) |
| ||
A. Malachi Mixon, III |
||||
/s/ Gerald B. Blouch |
President, Chief Operating Officer
and Director |
| ||
Gerald B. Blouch |
||||
/s/ Robert K. Gudbranson |
Senior Vice President
and Chief Financial Officer
(Principal Financial and Accounting Officer) |
| ||
Robert K. Gudbranson |
/s/ James C. Boland |
Director |
| ||
James C. Boland |
||||
/s/ Michael F. Delaney |
Director |
| ||
Michael F. Delaney |
||||
/s/ C. Martin Harris, M.D. |
Director |
| ||
C. Martin Harris, M.D. |
/s/ Bernadine P. Healy, M.D. |
Director |
| ||
Bernadine P. Healy, M.D. |
||||
/s/ John R. Kasich |
Director |
| ||
John R. Kasich |
||||
/s/ Dale C. LaPorte |
Director |
| ||
Dale C. LaPorte |
/s/ Dan T. Moore, III |
Director |
| ||
Dan T. Moore, III |
||||
/s/ Joseph B. Richey, II |
Director |
| ||
Joseph B. Richey, II |
||||
/s/ William M. Weber |
Director |
| ||
William M. Weber |
Exhibit
Number |
Exhibit
Description |
|
4.1 |
Second Amended and Restated Articles of Incorporation of the registrant. (1) |
|
4.2 |
Code of Regulations of the Company, as last amended on May 21, 2009. (2) |
|
4.3 |
Specimen Share Certificate for Common Shares. (3) |
|
4.4 |
Rights Agreement between the Company and National City Bank, dated as of July 8, 2005. (4) |
|
4.5 |
Invacare Corporation 2003 Performance Plan, as amended. (5) |
|
5.1 |
Opinion of Calfee, Halter & Griswold LLP. (x) |
|
23.1 |
Consent of Ernst & Young LLP. (x) |
|
23.2 |
Consent of Calfee, Halter & Griswold LLP (included in Exhibit 5.1 of this Registration Statement). |
|
24.1 |
Power of attorney (included on the signature pages of this Registration Statement). |
|
__________________ |
(1) |
Incorporated herein by reference to Exhibit 3(a) to the registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008. |
(2) |
Incorporated herein by reference to Exhibit 3.1 to the registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2009. |
(3) |
Incorporated herein by reference to Exhibit 4(a) to the registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2005. |
(4) |
Incorporated herein by reference to Exhibit 4.1 to the registrant’s Current Report on Form 8-K, dated July 8, 2005. |
(5) |
Incorporated herein by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K, dated May 28, 2009. |
(x) |
Filed herewith. |